Prevalence study of depression and anxiety during the COVID-19 pandemic: Literature review
DOI:
https://doi.org/10.33448/rsd-v11i13.35245Keywords:
COVID-19; Depression; Anxiety; Prevalence.Abstract
The COVID-19 pandemic, which began at the end of 2019 in China, directly affected the mental health, not only of those who suffered from the disease, but also everyone who was involved in some way in the care of these patients. This study aims to analyze the prevalence of depression and anxiety during the pandemic period in which we live, through the methodology of a qualitative and quantitative literature review, in order to verify whether or not there was an increase in the number of people with symptoms. of depression and anxiety. It was noticed, through the research, that most of the studies identified that during the pandemic a greater number of people acquired such diseases that they did not have, also showing that women and younger people were the group of people who suffered the most from the disease. This is mainly due to the fact of having had direct contact with the Sars-CoV-2 virus, and also the change in the lifestyle of each one. The analyzed works also indicated that, in addition to the patients, a part of the health professionals also contracted signs of depression and anxiety, since they had to deal with an exhausting workday, or even witness situations never seen before.
References
Barros, M. B. A. et al. (s.d.). Report on sadness/depression, nervousness/anxiety and sleep problems in the Brazilian adult population during the COVID-19 pandemic. https://pubmed.ncbi.nlm.nih.gov/32844918/
Bernaras, E., Jaureguizar, J., & Garaigordobil, M. (2019). Child and adolescent depression: a review of theories, evaluation instruments, prevention programs, and treatments. Frontiers in psychology, 10, 543.
Brasil. Secretarias Estaduais de Saúde. (2022). Painel Coronavírus. 2022. Disponível em: https://covid.saude.gov.br/.
Deng, J, et al. (2019). The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis.. https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/pt/covidwho-1263856
Goularte, J. F. et al. (2021). COVID-19 and mental health in Brazil: Psychiatric symptoms in the general population. J Psychiatr Res. 132(1), 32-7.
Hossain, M. et al. (2020). Epidemiology of mental health problems in COVID-19: a review. F1000Res. 9(1), 636. doi: 10.12688/f1000research.24457.1.
Jakobsen, J. C., Gluud, C. & Kirsch, I. (2020). Should antidepressants be used for major depressive disorder? BMJ Evidence-Based Medicine. 25(4), 130-6.
Jhons, G. et al. (s.d.). The global prevalence of depression and anxiety among doctors during the covid-19 pandemic: Systematic review and meta-analysis. https://www.sciencedirect.com/science/article/pii/S0165032721012477
Laboissiere, P. (2017). No dia mundial da saúde, OMS alerta sobre depressão. 2017. Disponível em: http://www.revistahcsm.coc.fiocruz.br/no-dia-mundial-da-saude-omsalerta-sobre-depressao/.
Lakatos, E. M., & Marconi, M. A. (2003). Fundamentos de metodologia científica. (5ª ed.). Atlas.
Lopes, J. M. et al. (s.d.). Uso elevado de psicofármacos durante a pandemia da COVID-19: uma análise a partir de levantamentos epidemiológicos. file:///C:/Users/User/Downloads/31180-Article-355934-1-10-20220626.pdf
Mazza, M.G. et al. (s.d.). Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. https://www.sciencedirect.com/science/article/pii/S0889159120316068?via%3Dihub
Morales, A. J. et al. (2020). COVID-19 in Latin America: The implications of the first confirmed case in Brazil. Travel Med Infect Dis, 35(1), 101613, 2020.
Rubert, C., & Duschle, R. A. N. (2021). Assistência farmacêutica durante a pandemia da Covid-19: revisão da literatura. Revista Interdisciplinar de Ensino, Pesquisa e Extensão Unicruz, 8(1), 255-268. https://doi.org/10.33053/revint.v8i1.316.
Salari, N. et al. (s.d.). The prevalence of stress, anxiety and depression within front-line healthcare workers caring for COVID-19 patients: a systematic review and meta-regression. https://human-resources-health.biomedcentral.com/articles/10.1186/s12960-020-00544-1
Santomauro, D. F. et al. (2020). Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02143-7/fulltext
Santos, K. M. R. et al. (s.d.). Depressão e ansiedade em profissionais de enfermagem durante a pandemia da covid-19. https://www.scielo.br/j/ean/a/DfmDPNnHcwnVymcDsHDc6hp/
Slusarsk, B. et al. (s.d.). Prevalence of Depression and Anxiety in Nurses during the First Eleven Months of the COVID-19 Pandemic: A Systematic Review and Meta-Analysis. https://www.mdpi.com/1660-4601/19/3/1154.
The Lancet.(2021). COVID-19 and mental health. 2021. Disponível em: https://www.thelancet.com/action/showPdf?pii=S2215-0366%2821%2900005-5.
Turan, O. et al. (s.d.). Anxiety and depression levels of healthcare workers during Covid-19 pandemic. https://www.ajol.info/index.php/ahs/article/view/224675
Umakanthan, S. et al. (2019). Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Postgrad Med J, v. 96, n. 1142, p. 753-758, 2020.
WHO. World Health Organization. (2021). Coronavirus disease (COVID-19): How is it transmitted? 2021. https://www.who.int/news-room/questions-andanswers/item/coronavirus-disease-covid-19-how-is-it-transmitted.
Yuki, K.; Fujiogi, M.; & Koutsogiannaki, S.(2020). COVID-19 pathophysiology: A review. Clin Immunol, 215(1), 108427, 2020.
Zhang, S. X. et al. (2021). Predictors of Depression and Anxiety Symptoms in Brazil during COVID-19. Int J Environ Res Public Health, 18(13), 7026, 2021.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Lucas Matheus Mocelin; José Roberto Alves Filho
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
